Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | BLM | P54132 | 1/20 | 0.43 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | LDHA | P00338 | 1/20 | 0.31 |
| ▸ | LDHB | P07195 | 1/20 | 0.31 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | FDPS | P14324 | 1/20 | 0.30 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11050625 | 0.87 | TSHR (0.42) | LMNAALOX15BLMPMP22ALDH1A1 | |
| SCHEMBL17550605 | 0.87 | LMNA (0.41) | LMNAALOX15BLMPMP22TDP1 | |
| SCHEMBL1090931 | 0.85 | LMNA (0.38) | LMNAALOX15BLMPMP22ALDH1A1 | |
| SCHEMBL25917062 | 0.82 | LMNA (0.35) | LMNAALOX15BLMPMP22ALDH1A1 | |
| SCHEMBL23128926 | 0.80 | — | — | |
| SCHEMBL27575205 | 0.79 | TDP1 (0.33) | LMNAALOX15BLMPMP22TDP1 | |
| SCHEMBL1053410 | 0.79 | LMNA (0.33) | LMNAALOX15BLMPMP22MAPT | |
| SCHEMBL15128371 | 0.79 | LMNA (0.33) | LMNAALOX15BLMPMP22MAPT | |
| Pivalamide SCHEMBL2484 | 0.78 | — | — | |
| SCHEMBL410733 | 0.78 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1052984-B1 | ANTIBACTERIAL AGENTS | VERNALIS OXFORD LTD (GB) | 2004-05-12 | — | — | EP | claimed |
| US-20020165167-A1 | Antibacterial agents | BRITISH BIOTECH PHARMACEUTICALS LTD. (GB) | 2002-11-07 | — | — | US | claimed |
| US-10919835-B2 | Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoids | Io Therapeutics, Inc. (US) | 2021-02-16 | — | — | US | disclosed |
| EP-3725801-A2 | AMINO DIACIDS CONTAINING PEPTIDE MODIFIERS | Chemical & Biopharmaceutical Laboratories of Patras S.A. (GR) | 2020-10-21 | — | — | EP | disclosed |
| US-20200190008-A1 | COMPOUNDS AND SYNTHETIC METHODS FOR THE PREPARATION OF RETINOID X RECEPTOR-SPECIFIC RETINOIDS | NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT | 2020-06-18 | — | — | US | disclosed |
| EP-2975620-B1 | ALUMINUM ELECTROLYTIC CAPACITOR-USE ELECTROLYTIC SOLUTION AND ALUMINUM ELECTROLYTIC CAPACITOR USING SAME | SANYO CHEMICAL IND LTD (JP) | 2019-05-22 | — | — | EP | disclosed |
| CN-105190809-B | Electrolyte for aluminum electrolytic capacitor and use its aluminium electrolutic capacitor | 三洋化成工业株式会社 | 2017-12-12 | — | — | CN | disclosed |
| US-9793059-B2 | Electrolytic solution for aluminum electrolytic capacitor and aluminum electrolytic capacitor using the same | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2017-10-17 | — | — | US | disclosed |
| US-20160020036-A1 | ELECTROLYTIC SOLUTION FOR ALUMINUM ELECTROLYTIC CAPACITOR AND ALUMINUM ELECTROLYTIC CAPACITOR USING THE SAME | SANYO CHEMICAL INDUSTRIES, LTD. (JP) | 2016-01-21 | — | — | US | disclosed |
| EP-2975620-A1 | ALUMINUM ELECTROLYTIC CAPACITOR-USE ELECTROLYTIC SOLUTION AND ALUMINUM ELECTROLYTIC CAPACITOR USING SAME | Sanyo Chemical Industries, Ltd. (JP) | 2016-01-20 | — | — | EP | disclosed |
| CN-105190809-A | Aluminum electrolytic capacitor-use electrolytic solution and aluminum electrolytic capacitor using same | SANYO CHEMICAL IND LTD | 2015-12-23 | — | — | CN | disclosed |
| WO-2001018072-A1 | PROCESS FOR PRODUCING CROSS-LINKED POLYALLYLAMINE POLYMER | THE DOW CHEMICAL COMPANY (US) | 2001-03-15 | — | — | WO | disclosed |
| US-6180754-B1 | CROSSLINKING POLYALLYLAMINE POLYMER IN SOLUTION | THE DOW CHEMICAL COMPANY | 2001-01-30 | — | — | US | disclosed |
| EP-1052984-A1 | ANTIBACTERIAL AGENTS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 2000-11-22 | — | — | EP | disclosed |
| WO-1999039704-A1 | ANTIBACTERIAL AGENTS | BRITISH BIOTECH PHARMACEUTICALS LIMITED (GB) | 1999-08-12 | — | — | WO | disclosed |
| WO-1998007653-A1 | CHIRAL HYDRIDE COMPLEXES | ZEELAND CHEMICALS, INC. (US) | 1998-02-26 | — | — | WO | disclosed |
| CN-1125939-A | Process for producing acyloxybenzenesulfonic acid or salt thereof | KAO CORP (JP) | 1996-07-03 | — | — | CN | disclosed |
| US-4481373-A | CATALYTIC OXIDATION OF OLEFINS IN PRESENCE OF TERTIARY AMINE OF AMIDE | TOA NENRYO KOGYO KABUSHIKI KAISHA (JP) | 1984-11-06 | — | — | US | disclosed |
| US-4321198-A | Polyimide derivatives having acetylenic amic acid groups | PLASTICS ENGINEERING COMPANY (US) | 1982-03-23 | — | — | US | disclosed |
| US-4168360-A | CROSSLINKED, INSOLUBLE, INFUSIBLE COATINGS AND MOLDING MATERIALS | PLASTICS ENGINEERING COMPANY (US) | 1979-09-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200190008-A1 | COMPOUNDS AND SYNTHETIC METHODS FOR THE PREPARATION OF RETINOID X RECEPTOR-SPECIFIC RETINOIDS | RXRG, RXRB, RXRA | LMNA 1712/4885ALOX15 1765/4885BLM 1448/4885 |
| US-10919835-B2 | Compounds and synthetic methods for the preparation of retinoid X receptor-specific retinoids | RXRG, RXRB, RXRA | LMNA 1712/4885ALOX15 1765/4885BLM 1448/4885 |
| US-20020165167-A1 | Antibacterial agents | CBR1, CBR3, SIGMAR1 | LMNA 578/4885ALOX15 2137/4885BLM 2628/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.